Successful Market Access of SaMD & MDSW: Decoding the Confusion in MedTech Software Development
- Avania
- Regulatory Affairs
Software as a medical device (SaMD) is an ever-evolving field, whether it’s the latest updates in risk classification or optimizing your use of the FDA Pre-Cert program for more iterative product development, it is important to know where you stand and what data you need to be successful. Read our white paper to “decode the confusion” in MedTech software development and keep your SaMD project on time and on budget.
Related Reading
Event / Regulatory Affairs
Medical Device Submissions Workshops – Premarket Approval (PMA)
8:30 am – 4:30 pm ET
February 6-7, 2025
Our in-depth device submissions workshops will provide real-world case studies, tips and best practices directly from FDA and industry experts.
Event / Regulatory Affairs
Medical Device Submissions Workshops – Investigational Device Exemption (IDE)
8:30 am – 5:15 pm ET
February 5, 2025
Our in-depth device submissions workshops will provide real-world case studies, tips and best practices directly from FDA and industry experts.
Event / China / Regulatory Affairs
China Regulatory Workshop
November 19, 2024 | 11:30 AM – 6:30 PM PT November 20, 2024 | 8:15 AM – 4:00 PM PT
Get the latest on new policy updates and guidance for the clinical evaluation of medical devices.
Event / Regulatory Affairs
Medical Device Submissions Workshops – 510(k) and De Novo
8:30 am – 4:15 pm ET
February 3-4, 2025
Our in-depth device submissions workshops will provide real-world case studies, tips and best practices directly from FDA and industry experts.
News / Regulatory Affairs
Guardant Health’s Shield™ Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening
July 31, 2024
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the U.S. Food and Drug Administration (FDA) has approved the company’s Shield™ blood test for colorectal cancer (CRC) screening in adults age 45 and older who are at average risk for the disease.
Event / Digital Health / Regulatory Affairs
AdvaMed Cybersecurity Summit
November 13, 2024
8:15 AM – 6:00 PM
Join us in Washington, D.C. for our Cybersecurity Summit that will address the future of medical device cybersecurity and changes in the industry landscape related to FDA requirements.
Resource / Regulatory Affairs
MedTech Reimbursement Playbook
July 17, 2024
Learn the basic principles of how medical technologies are covered and paid by insurers and the challenges medtech companies face.
Resource / Regulatory Affairs
PFAS in Medtech
March 8, 2024